Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis.

Corbaux P, You B, Kagimura T, Glasspool RM, McNeish I, Cook A, Mirza MR, Lindemann K, Tinker AV, Welch S, Ray-Coquard IL, Subtil F, Colomban O, Péron J, Karamouza E, Kelly C, Lewsley LA, Paoletti X, Yanaihara N

Open source

DOI: 10.1016/j.ijgc.2025.102719
Published: 2026 Jan
Container: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijgc.2025.102719,
  title = {Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis.},
  author = {Corbaux P and You B and Kagimura T and Glasspool RM and McNeish I and Cook A and Mirza MR and Lindemann K and Tinker AV and Welch S and Ray-Coquard IL and Subtil F and Colomban O and Péron J and Karamouza E and Kelly C and Lewsley LA and Paoletti X and Yanaihara N},
  year = {2026},
  journal = {International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  doi = {10.1016/j.ijgc.2025.102719},
  url = {https://doi.org/10.1016/j.ijgc.2025.102719}
}

RIS

TY  - JOUR
TI  - Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis.
AU  - Corbaux P
AU  - You B
AU  - Kagimura T
AU  - Glasspool RM
AU  - McNeish I
AU  - Cook A
AU  - Mirza MR
AU  - Lindemann K
AU  - Tinker AV
AU  - Welch S
AU  - Ray-Coquard IL
AU  - Subtil F
AU  - Colomban O
AU  - Péron J
AU  - Karamouza E
AU  - Kelly C
AU  - Lewsley LA
AU  - Paoletti X
AU  - Yanaihara N
PY  - 2026
JO  - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
DO  - 10.1016/j.ijgc.2025.102719
UR  - https://doi.org/10.1016/j.ijgc.2025.102719
ER  -

APA

P, C., B, Y., T, K., RM, G., I, M., A, C., MR, M., K, L., AV, T., S, W., IL, R., F, S., O, C., J, P., E, K., C, K., LA, L., X, P., & N, Y. (2026). Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. https://doi.org/10.1016/j.ijgc.2025.102719

Source records

pubmed · retrieved 2026-09-26T19:49:02.770Z